TIGIT and neoplasm: A blocking antibody against TIGIT, an inhibitory receptor on NK cells bearing ITIM- and Ig tail-tyrosine (ITT)-like motif, can reverse the exhausted phenotype of TIGIT-upregulated tumor-infiltrated NK cells, constrain tumor growth, and improve the survival tumor-bearing mice in vivo (157, 158).